New Delhi, Sep 8 Covid-19 is raging like a wild fire across the country, making India the second worst hit country after the US.
But there is a bright spot amid this mayhem India's first indigenous Covid-19 vaccine, Covaxin developed by Bharat Biotech, may be launched in early 2021.
Covaxin has successfully completed Phase 1 trials and the Centre has given its approval for Phase 2 of clinical trials from September 7.
Speaking to , Sanjay Rai, Professor, Community Medicine, and Principal Investigator for Covid-19 vaccine trial at AIIMS, said: "Phase 1 trial has been successfully completed. Phase 2 trial is most likely to get completed sometime in October. After this, the Phase 3 trial will begin. Covaxin may be launched in early 2021
( With inputs from IANS )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor